Anti Infectives - Innovators

Istvan Molnar

raclauswalker — Mon, 30 Mar 2020 20:53:21 +0000

Professor, School of Natural Resources and the Environment

Istvan Molnar

Interested in discovering new natural product and unnatural natural product small molecule secondary metabolites with antiinfective activities. Using combinatorial synthetic microbiology to improve their production, and to generate derivatives with improved activity, higher specificity, better safety.

Arun Dhar

raclauswalker — Mon, 30 Mar 2020 20:50:25 +0000

Associate Professor, School of Animal and Comparative Biomedical Sciences

Director, Aquaculture Pathology Laboratory

Arun Dhar

Website

Innovators

One of the research priorities in our lab is to develop CRISPR-Cas based therapies against viral diseases in shrimp. Another important project involves developing anti-bacterial therapies using plant natural extracts.

Michael David Leslie Johnson

raclauswalker — Mon, 30 Mar 2020 20:47:38 +0000

Assistant Professor, Department of Immunobiology

Michael David Leslie Johnson

Website

Innovators

The Johnson Laboratory specializes in understanding how bacteria process toxic metals such as copper. Recently, we have found a novel compound that synergizes with copper to act in an antimicrobial capacity in culture, and reduce bacterial burden in the animal models. With support from Tech Launch Arizona, we have begun derivatizing this compound to make more novel therapeutics with preliminary success.

Kerry Cooper

raclauswalker — Mon, 30 Mar 2020 20:45:48 +0000

Assistant Professor, School of Animal and Comparative Biomedical Sciences

Kerry Cooper

Website

Innovators

My research interest in development of prevention and treatment options for foodborne pathogens involves looking for alternative treatment and prevention methods from traditional antibiotics due to resistance for those pathogens that are traditionally treated with antibiotics like Salmonella and Campylobacter. While looking for alternative treatment options for foodborne pathogens like Shiga toxin-producing Escherichia coli (STEC) that cannot be treated with antibiotics. Ultimately our goal is to find a therapeutic/preventative agent(s) that would effectively work as a treatment against the different foodborne pathogens, while also improving preventative methods in agriculture over the traditional method of placing large amounts of antimicrobials in animal feed.

Elizabeth Connick

raclauswalker — Mon, 30 Mar 2020 20:44:18 +0000

Chief, Division of Infectious Diseases, Department of Medicine

Elizabeth Connick

Innovators

Immunotherapy to suppress or cure HIV infection

Sam Campos

raclauswalker — Mon, 30 Mar 2020 20:42:29 +0000

Associate Professor, Department of Immunobiology

Sam Campos

Website

Innovators

Development and testing of antivirals

Jaime Boehmer

raclauswalker — Mon, 30 Mar 2020 20:40:46 +0000

Associate Dean for Research and Graduate Studies, College of Veterinary Medicine

Jaime Boehmer

Innovators

I am not currently conducting laboratory research, but my prior research program focused on host-pathogen interactions in food animal species, with a particular focus on identifying biomarkers of inflammation that could be used to evaluate the effectiveness of anti-inflammatory compounds in the treatment of bovine mastitis.